510(k) K050613
K050613 is an FDA 510(k) premarket notification submitted by Biokit, S.A. for the device "QUANTIA BETA-2 MICROGLOBULIN". The FDA issued a decision of Substantially Equivalent on Aug 16, 2005. The device falls under product code JZG (System, Test, Beta-2-Microglobulin Immunological), a Class II device regulated under 21 CFR 866.5630. Biokit, S.A. has 22 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 16, 2005
- Date Received
- Mar 10, 2005
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Beta-2-Microglobulin Immunological
- Device Class
- Class II
- Regulation Number
- 866.5630
- Review Panel
- IM
- Submission Type
- 510(k) Exempt
Need the full FDA record for Biokit, S.A.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.